Histologic regression (
perianal disease
DISEASE, HSIL
At screening HRA, all study participants had residual anal HSIL as documented by HRA, which ranged from minimal disease (1 or 2 small lesions, < 5 mm in size) to extensive intra-anal and perianal disease.